Jason M. Urban, PhD, CA-AM Alexion Pharmaceuticals

Jason Urban, PhD is Senior Director, Quality Risk Management at Alexion Pharmaceuticals. In this role Jason is responsible for providing risk expertise, driving methodology, focusing on prioritization of risks, and maintaining oversight of enterprise Quality risk registers.

Jason brings 18 years of leadership across the public and private sectors in the fields of risk management, operations, analytics, and business strategy. Prior to his current role, Jason was with Bristol-Myers Squibb where, as the Head of External Engagement and the Global Process Owner for Risk Management, he led the strategy and implementation of a global GxP Quality Risk Management process network, driving harmonized and standardized approaches to the early identification, mitigation, escalation, and measurement of risk. Prior to this, Jason worked at Celgene Corporation and at the U.S. Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER), where he led policy and risk program development activities in the areas of supply chain, regulatory compliance, operations, and strategy.

Jason holds a PhD in Cellular Biology with a focus on oncology and completed his postdoctoral work in molecular neuroscience and cell/gene therapies. Jason is also an active member of the editorial board of Life Science Leader Magazine.